Net Cash Provided by (Used in) Operating Activities in USD of Scinai Immunotherapeutics Ltd. from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Scinai Immunotherapeutics Ltd. quarterly and annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2021 to 2024.
  • Scinai Immunotherapeutics Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2023 was $3,059,000, a 177% decline year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $6,335,000, a 32% increase from 2023.
  • Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $9,382,000, a 29% decline from 2022.
  • Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $7,265,000, a 2.2% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Scinai Immunotherapeutics Ltd. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $3,059,000 -$1,954,000 -177% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $1,105,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1

Scinai Immunotherapeutics Ltd. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,335,000 +$3,047,000 +32% 01 Jan 2024 31 Dec 2024 20-F 07 May 2025 2024 FY
2023 $9,382,000 -$2,117,000 -29% 01 Jan 2023 31 Dec 2023 20-F 07 May 2025 2024 FY
2022 $7,265,000 +$161,000 +2.2% 01 Jan 2022 31 Dec 2022 20-F 07 May 2025 2024 FY
2021 $7,426,000 01 Jan 2021 31 Dec 2021 20-F 15 May 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.